Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · H2 FY26

G M Polyplast H2 FY26 Results: Net Profit ₹4.8 Cr, Up 26.3% YoY

G M Polyplast Ltd reported revenue from operations of ₹58.4 Cr (+9.6% YoY) and net profit of ₹4.8 Cr (+26.3% YoY) for H2 FY26.

H2 FY26 at a glance · ₹ crore
MetricH2 FY26H1 FY26H2 FY25
Revenue from operations58.444.653.3
Other income0.10.00.0
Total income58.544.653.3
Profit before exceptional items & tax6.24.95.1
Profit before tax6.24.95.1
Net profit4.83.53.8
Operating margin10.6%11.0%9.6%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year+26.30%
Net profit, quarter on quarter+37.10%
Revenue, year on year+9.60%
Source

BSE results filing, BSE: 543239. Figures extracted from the filing.

Read the filing ↗

G M Polyplast Ltd: key numbers

Share price
₹65.30
Market cap
₹87.89 Cr
Revenue (annual)
₹103.0 Cr
Net profit (annual)
₹8.27 Cr
P/E (TTM)
10.6×Sector 53.6×
Promoter holding
73.54%+0.00% QoQ
FII holding
1.27%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from G M Polyplast Ltd

All →
19:26 IST BSE
Merger & Restructuring

G M Polyplast Merger & Restructuring Worth ₹2 Cr

G M Polyplast Ltd received shareholder approval for the sale of machinery and spare parts to its wholly-owned subsidiary, Regranix Private Limited, for up to ₹2 Crore.

Value
₹2.00 Cr
Execution
One year
19:22 IST BSE
Management Change

G M Polyplast Management Change

G M Polyplast Limited has re-appointed Mr. Dinesh Balbeer Sharma as Managing Director and Chief Financial Officer. His tenure is effective from September 07, 2026.

14:37 IST BSE
Annual General Meeting

G M Polyplast Annual General Meeting

G M Polyplast reported the outcome of its 23rd AGM held 7 September 2026. All ordinary and special resolutions, including borrowing powers and related-party dealings with Regranix, were approved.